Tandem to file tubeless insulin pump with FDA this quarter

Tandem to file tubeless insulin pump with FDA this quarter is a pharma and life sciences industry update from MedTech Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Elise Reuter · 2026-05-08

The new version of Tandem’s Mobi pump would be the diabetes technology company’s first tubeless device.

Source: MedTech Dive